litlas
Log inCreate account

Aron Goldhirsch

Active 1983–2025

214
Papers
66,479
Citations
127
h-index
212
i10-index

Citations

Citations per year for Aron Goldhirsch1971: 1 citations1974: 3 citations1980: 1 citations1981: 1 citations1985: 6 citations1986: 4 citations1987: 7 citations1988: 4 citations1989: 9 citations1990: 16 citations1991: 15 citations1992: 21 citations1993: 20 citations1994: 38 citations1995: 41 citations1996: 45 citations1997: 49 citations1998: 65 citations1999: 71 citations2000: 129 citations2001: 166 citations2002: 168 citations2003: 227 citations2004: 204 citations2005: 253 citations2006: 348 citations2007: 408 citations2008: 466 citations2009: 482 citations2010: 505 citations2011: 524 citations2012: 483 citations2013: 557 citations2014: 482 citations2015: 543 citations2016: 578 citations2017: 503 citations2018: 431 citations2019: 1,601 citations2020: 1,776 citations2021: 1,437 citations2022: 1,212 citations2023: 815 citations2024: 1,261 citations2025: 521 citations2026: 16 citations1972–1973: no citations, so these years are not shown1975–1979: no citations, so these years are not shown1982–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,541 citing papers, 22.1% of this breakdownChina: 1,782 citing papers, 8.7% of this breakdownItaly: 1,531 citing papers, 7.5% of this breakdownUnited Kingdom: 1,296 citing papers, 6.3% of this breakdownGermany: 1,058 citing papers, 5.1% of this breakdownFrance: 785 citing papers, 3.8% of this breakdownCanada: 755 citing papers, 3.7% of this breakdownSwitzerland: 664 citing papers, 3.2% of this breakdownAustralia: 596 citing papers, 2.9% of this breakdownNetherlands: 591 citing papers, 2.9% of this breakdownBelgium: 560 citing papers, 2.7% of this breakdownSpain: 552 citing papers, 2.7% of this breakdown
0%22.1%Other 28.4%

Institutions

Fields

  • Medicine52.1%
  • Biochemistry, Genetics and Molecular Biology39.6%
  • Immunology and Microbiology1.8%
  • Computer Science1.6%
  • Health Professions0.9%
  • Engineering0.7%
  • Other3.3%

Topics

  • Breast Cancer Treatment Studies12.1%
  • HER2/EGFR in Cancer Research6.5%
  • Breast Lesions and Carcinomas4.6%
  • Advanced Breast Cancer Therapies3.1%
  • Cancer Immunotherapy and Biomarkers2.6%
  • Estrogen and related hormone effects2.6%
  • Other68.5%

Coauthors

All papers

Open in search
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Authors: Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 cited by 3,715

  2. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

    Authors: Aron Goldhirsch, W. C. Wood, Alan S. Coates, Richard D. Gelber, Beat Thürlimann, Hans-Jörg Senn - Annals of Oncology 2011 cited by 3,881

  3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  4. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis

    Authors: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Tommaso De Pas, Marco Martinetti, Giuseppe Viale, Richard D. Gelber, Aron Goldhirsch - The Lancet Oncology 2018 cited by 993

  5. Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

    Authors: Martine Piccart, Marion Procter, Brian Leyland‐Jones, Aron Goldhirsch, Michael Untch, Ian Smith, Luca Gianni, José Baselga, Richard H. Bell, Christian Jackisch, David Cameron, Mitch Dowsett, Carlos H. Barrios, Günther Steger, Chiun‐Sheng Huang, Michael Andersson, Moshe Inbar, Mikhail Lichinitser, István Láng, Ulrike Nitz, Hiroji Iwata, Christoph Thomssen, Caroline Lohrisch, Thomas Suter, Josef Rüschoff, Tamás Sütö, Victoria Greatorex, Carol Ward, Carolyn Straehle, Eleanor McFadden, Mirko Dolci, Richard D. Gelber - New England Journal of Medicine 2005 cited by 5,098

  6. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Richard D. Gelber, Michael Gnant, Martine Piccart, Beat Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Viviana Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  7. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

    Authors: David Cameron, Martine Piccart, Richard D. Gelber, Marion Procter, Aron Goldhirsch, Evandro de Azambuja, Gilberto de Castro, Michael Untch, Ian Smith, Luca Gianni, José Baselga, N. Al-Sakaff, Sabine Lauer, Eleanor McFadden, Brian Leyland‐Jones, Richard H. Bell, Mitch Dowsett, Christian Jackisch - The Lancet 2017 cited by 1,041

  8. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    Authors: Marco Colleoni, Zhuoxin Sun, Karen N. Price, Per Karlsson, John Forbes, Beat Thürlimann, Lorenzo Gianni, Monica Castiglione, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2016 cited by 623

  9. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    Authors: Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jérusalem, Rupert Bartsch, Manuela Rabaglio, Roswitha Kammler, Rudolf Maibach, Mark J. Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M. Regan, Fabrice André, Debora Fumagalli, Richard D. Gelber, Theodora Goulioti, Anita Hiltbrunner, Rita L. Hui, Heidi Roschitzki, Barbara Ruepp, Frances M. Boyle, Rolf A. Stahel, Stefan Aebi, Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier - The Lancet Oncology 2019 cited by 477

  10. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    Authors: Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Žgajnar, Mario Taffurelli, David R. G. Littlejohn, Michael Knauer, Carlo Tondini, Angelo Di Leo, Marco Colleoni, Meredith M. Regan, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Frances M. Boyle, Guy Jérusalem, Rolf A. Stahel, Stefan Aebi, Michael J. Green, Per Karlsson, Ingrid Kössler, István Láng, Anita Hiltbrunner, Jürg Bernhard, Stamatina Fournarakou, Roswitha Kammler, Rudolf Maibach, Manuela Rabaglio, Karin Ribi, Heidi Roschitzki, Susanne Roux, Barbara Ruepp, Caitlin Mahoney, Karen N. Price, L. J. Blacher, Tara Scolese, Karolyn Scott, Sandra Lippert, Theresa Julia Zielinski, Mauro G. Mastropasqua, Stefania Andrighetto, Patrizia Dell’Orto, Giuseppe Renne, Giancarlo Pruneri, Silvia Dellapasqua, Monica Iorfida, Giuseppe Cancello, Emilia Montagna, Anna Cardillo, G. Peruzzotti, R. Ghisini, Alberto Luini, Umberto Veronesi, Mattia Intra, Oreste ­Gentilini, Stefano Zurrida, Giuseppe Curigliano, Franco Nolè, Roberto Orecchia, Marisa Cristina Leonardi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Diana Crivellari, Sandro Morassut, Mario Mileto, Erica Piccoli, Andreas Veronesi, Marisa Donatella Magri, Angelo Buonadonna, Ezio Candiani, Antonino Carbone, Tiziana Perin, Rachele Volpe, Mario Roncadin, Mauro Arcicasa, Francesco Coran, Manuela Lagrassa, A. Recalcati, Maria Emanuela Limonta, Paolo Tricomi, P. Fenaroli, Elisabetta Candiago, Laura Cattaneo, Alberto Gianatti, Donatella Santini, Sylvie Maweja, Philippe Delvenne, Andrée Rorive, Joëlle Collignon, Jean-Rémi Garbay, Marie‐Christine Mathieu, Hanne Galatius, J Hoffmann, Peer Schousen and 102 more - The Lancet Oncology 2018 cited by 565

  11. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    Authors: Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Eva Ciruelos, Harold J. Burstein, Hervé Bonnefoi, Meritxell Bellet, Silvana Martino, Charles E. Geyer, Matthew P. Goetz, Vered Stearns, Graziella Pinotti, Fabio Puglisi, Simon Spazzapan, Miguel Ángel Climent, Lorenzo Pavesi, Thomas Ruhstaller, Nancy E. Davidson, Robert L. Coleman, Marc Debled, Stefan Buchholz, James N. Ingle, Eric P. Winer, Rudolf Maibach, Manuela Rabaglio, Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 cited by 673

  12. Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis

    Authors: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Giuseppe Viale, Tommaso De Pas, Eleonora Pagan, Elisabetta Pennacchioli, Emilia Cocorocchio, Pier Francesco Ferrucci, Filippo de Marinis, Richard D. Gelber, Aron Goldhirsch - JNCI Journal of the National Cancer Institute 2019 cited by 282

  13. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

    Authors: José Baselga, Ian Bradbury, Holger Eidtmann, Serena Di Cosimo, Evandro de Azambuja, Claudia Aura, Henry Gómez, Phuong Dinh, Karine Fauria, Veerle Van Dooren, Gursel Aktan, Aron Goldhirsch, Tsai-Wang Chang, Zsolt Horváth, M.A. Coccia-Portugal, Julien Dômont, Ling-Min Tseng, Georg Kunz, Joohyuk Sohn, Semiglazov Vf, Guillermo Lerzo, Markéta Palácová, Volodymyr Probachai, Lajos Pusztai, Michael Untch, Richard D. Gelber, Martine Piccart - The Lancet 2012 cited by 1,314

  14. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    Authors: Olivia Pagani, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis - Journal of Clinical Oncology 2022 cited by 154

  15. Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

    Authors: Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset‐Jablonski, Simona Borštnar, Junko Takei, Jeong Eun Lee, Janice M. Walshe, Manuel Ruíz‐Borrego, Halle C. F. Moore, Christobel Saunders, Vesna Bjelic‐Radisic, Sneẑana Šušnjar, Fátima Cardoso, Karen L. Smith, Teresa I. Ferreiro, Karin Ribi, Kathryn J. Ruddy, Roswitha Kammler, Sarra El-Abed, Giuseppe Viale, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani - New England Journal of Medicine 2023 cited by 215

  16. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Authors: Viviana Galimberti, Bernard F. Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra, Oreste ­Gentilini, Mauro G. Mastropasqua, Giovanni Mazzarol, Samuele Massarut, Jean‐Remi Garbay, Janez Žgajnar, Hanne Galatius, A. Recalcati, David R. G. Littlejohn, Monika Bamert, Marco Colleoni, Karen N. Price, Meredith M. Regan, Aron Goldhirsch, Alan S. Coates, Richard D. Gelber, Umberto Veronesi - The Lancet Oncology 2013 cited by 1,229

  17. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    Authors: Olivia Pagani, Meredith M. Regan, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 cited by 747

  18. Breast cancer

    Authors: Umberto Veronesi, Peter Boyle, Aron Goldhirsch, Roberto Orecchia, Giuseppe Viale - The Lancet 2005 cited by 526

  19. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    Authors: Prudence A. Francis, Meredith M. Regan, Gini F. Fleming, István Láng, Eva Ciruelos, Meritxell Bellet, Hervé Bonnefoi, Miguel Ángel Climent, Gian Antonio Da Prada, Harold J. Burstein, Silvana Martino, Nancy E. Davidson, Charles E. Geyer, Barbara Walley, Robert E. Coleman, Pierre Kerbrat, Stefan Buchholz, James N. Ingle, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Marco Colleoni, Giuseppe Viale, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber - New England Journal of Medicine 2014 cited by 727

  20. Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

    Authors: Otto Metzger, Zhuoxin Sun, Giuseppe Viale, Karen N. Price, Diana Crivellari, Raymond Snyder, Richard D. Gelber, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch, Fátima Cardoso - Journal of Clinical Oncology 2013 cited by 343

  21. Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

    Authors: Fabio Conforti, Laura Pala, Eleonora Pagan, Vincenzo Bagnardi, Tommaso De Pas, Paola Queirolo, Elisabetta Pennacchioli, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci, Maristella Saponara, Gianmarco Orsolini, Paola Zagami, Eleonora Nicolò, Filippo de Marinis, Giampaolo Tortora, Emilio Bria, Saverio Minucci, Hadine Joffe, Paolo Veronesi, Jennifer A. Wargo, Rachel Rosenthal, Charles Swanton, Alberto Mantovani, Richard D. Gelber, Giuseppe Viale, Aron Goldhirsch, Giuseppe Giaccone - Clinical Cancer Research 2021 cited by 103

  22. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

    Authors: Giuseppe Curigliano, Daniela Cardinale, Thomas Suter, G. Plataniotis, Evandro de Azambuja, Maria Teresa Sandri, Carmen Criscitiello, Aron Goldhirsch, Carlo M. Cipolla, Fausto Roila - Annals of Oncology 2012 cited by 864

  23. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    Authors: Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A. Gusterson, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thürlimann, Elizabeth Murray, Giuseppe Viale, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2008 cited by 497

  24. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    Authors: Olivia Pagani, Prudence A. Francis, Gini F. Fleming, Barbara Walley, Giuseppe Viale, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Graziella Pinotti, Angelo Di Leo, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, Meredith M. Regan, for the SOFT and TEXT Investigators and International Breast Cancer Study Group - Journal of Clinical Oncology 2019 cited by 150